| EILIX | OSMCX | EILIX / OSMCX | |
| Total Expense Ratio | 1.06 | 2.13 | 50% |
| Annual Report Gross Expense Ratio | 1.23 | 2.13 | 58% |
| Fund Existence | 10 years | 28 years | - |
| Gain YTD | 3.834 | 2.732 | 140% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 1000 | 100,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 3.64M | 2.56B | 0% |
| Annual Yield % from dividends | 8.16 | 0.83 | 979% |
| Returns for 1 year | 20.02 | -6.51 | -307% |
| Returns for 3 years | 23.18 | -18.78 | -123% |
| Returns for 5 years | 6.09 | -38.65 | -16% |
| Returns for 10 years | 75.00 | -4.86 | -1,542% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| AIVOX | 12.83 | 0.18 | +1.42% |
| American Century International Opps A | |||
| VSFCX | 23.42 | 0.07 | +0.30% |
| Federated Hermes MDT Small Cap Value C | |||
| JFNIX | 81.99 | -0.52 | -0.63% |
| Janus Henderson Global Life Sciences I | |||
| RYEUX | 128.58 | -1.83 | -1.40% |
| Rydex Europe 1.25x Strategy H | |||
| SLRYX | 41.66 | -0.67 | -1.58% |
| SEI Large Cap Growth Y (SIMT) | |||